Search Results Search Sort by RelevanceMost Recent Case and Commentary Apr 2019 How Should Physicians Help Patients Understand Unknowns of Nanoparticle-Based Medicines? Nancy M. P. King, JD and Christine E. Bishop, MD, MA When an unproven intervention is a nanodrug, a physician’s role is especially difficult due to possibilities of unprecedented harms. AMA J Ethics. 2019;21(4):E324-331. doi: 10.1001/amajethics.2019.324. AMA Code Says May 2019 AMA Code of Medical Ethics’ Opinions Related to Ethics of Life-Sustaining Technologies Rachel F. Harbut How should physicians researching life-sustaining technologies consider their duties to enrolled subjects? AMA J Ethics. 2019;21(5):E416-420. doi: 10.1001/amajethics.2019.416. Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936. Case and Commentary Jun 2018 Is It Ethical to Treat Pain Differently in Children and Adults with Burns? Sharmila Dissanaike, MD Pain management of adult and pediatric burn patients should be individualized and include nonpharmacological treatment. AMA J Ethics. 2018;20(6):531-536. doi: 10.1001/journalofethics.2018.20.6.cscm1-1806. Case and Commentary Jun 2019 Does a Patient’s Trauma History Ethically Justify a Discriminatory Clinical Referral? John R. Stone, MD, PhD A “simplicity strategy” suggests expressing respect for persons and empathy and models inclusive group inquiry, epistemic humility, and justice. AMA J Ethics. 2019;21(6):E493-498. doi: 10.1001/amajethics.2019.493. Case and Commentary Mar 2020 How Should Organizations Respond to Repeated Noncompliance by Prominent Researchers? Min-Fu Tsan, MD, PhD and Grace L. Tsan, OD IRBs must report human subject research protocol deviations and university leadership might also need to motivate compliance with federal regulations. AMA J Ethics. 2020;22(3):E201-208. doi: 10.1001/amajethics.2020.201. Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353. Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368. Case and Commentary Aug 2022 When Experiencing Inequitable Health Care Is a Patient’s Norm, How Should Iatrogenic Harm Be Considered? Bantale Ayisire, MS, RN and Kristen R. Choi, PhD, RN Inequitable care and outcomes experienced by persons with mental illness have long been exacerbated by stigma expressed by clinicians. AMA J Ethics. 2022;24(8):E729-734. doi: 10.1001/amajethics.2022.729. Case and Commentary Apr 2022 ¿Los médicos deben ser activistas? Kristen N. Pallok, MD and David A. Ansell, MD, MPH AMA J Ethics. 2022;E254-260. doi: 10.1001/amajethics.2022.254. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary Apr 2019 How Should Physicians Help Patients Understand Unknowns of Nanoparticle-Based Medicines? Nancy M. P. King, JD and Christine E. Bishop, MD, MA When an unproven intervention is a nanodrug, a physician’s role is especially difficult due to possibilities of unprecedented harms. AMA J Ethics. 2019;21(4):E324-331. doi: 10.1001/amajethics.2019.324.
AMA Code Says May 2019 AMA Code of Medical Ethics’ Opinions Related to Ethics of Life-Sustaining Technologies Rachel F. Harbut How should physicians researching life-sustaining technologies consider their duties to enrolled subjects? AMA J Ethics. 2019;21(5):E416-420. doi: 10.1001/amajethics.2019.416.
Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936.
Case and Commentary Jun 2018 Is It Ethical to Treat Pain Differently in Children and Adults with Burns? Sharmila Dissanaike, MD Pain management of adult and pediatric burn patients should be individualized and include nonpharmacological treatment. AMA J Ethics. 2018;20(6):531-536. doi: 10.1001/journalofethics.2018.20.6.cscm1-1806.
Case and Commentary Jun 2019 Does a Patient’s Trauma History Ethically Justify a Discriminatory Clinical Referral? John R. Stone, MD, PhD A “simplicity strategy” suggests expressing respect for persons and empathy and models inclusive group inquiry, epistemic humility, and justice. AMA J Ethics. 2019;21(6):E493-498. doi: 10.1001/amajethics.2019.493.
Case and Commentary Mar 2020 How Should Organizations Respond to Repeated Noncompliance by Prominent Researchers? Min-Fu Tsan, MD, PhD and Grace L. Tsan, OD IRBs must report human subject research protocol deviations and university leadership might also need to motivate compliance with federal regulations. AMA J Ethics. 2020;22(3):E201-208. doi: 10.1001/amajethics.2020.201.
Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353.
Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368.
Case and Commentary Aug 2022 When Experiencing Inequitable Health Care Is a Patient’s Norm, How Should Iatrogenic Harm Be Considered? Bantale Ayisire, MS, RN and Kristen R. Choi, PhD, RN Inequitable care and outcomes experienced by persons with mental illness have long been exacerbated by stigma expressed by clinicians. AMA J Ethics. 2022;24(8):E729-734. doi: 10.1001/amajethics.2022.729.
Case and Commentary Apr 2022 ¿Los médicos deben ser activistas? Kristen N. Pallok, MD and David A. Ansell, MD, MPH AMA J Ethics. 2022;E254-260. doi: 10.1001/amajethics.2022.254.